Clinical Trial

ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
To find out if certain drug/therapy combinations that are targeted to individual patients based on characteristics of their disease types may help to control the disease.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-12-30; most recent amendment 2026-06-09.
Trial Details
NCT Number NCT07318389
Lead Sponsor M.D. Anderson Cancer Center
Conditions Dynamic Tumor Resistance, Metastatic Colorectal Cancer
Enrollment 100 participants
Start Date 2026-06-10
Primary Completion 2027-11-14 (estimated)
Study Completion 2029-11-14 (estimated)
Updated on ClinicalTrials.gov 2026-06-11